Identification of molecular markers of inflammatory mediators in posterior laryngitis due to laryngopharyngeal reflux and evolution with PPI treatment

Trial Profile

Identification of molecular markers of inflammatory mediators in posterior laryngitis due to laryngopharyngeal reflux and evolution with PPI treatment

Completed
Phase of Trial: Phase II/III

Latest Information Update: 15 Jan 2008

At a glance

  • Drugs Rabeprazole (Primary)
  • Indications Laryngopharyngeal reflux
  • Focus Pharmacodynamics
  • Most Recent Events

    • 15 Jan 2008 Status changed from recruiting to completed.
    • 05 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top